Do you want to read an article? Please log in or register.
Short-term effect on the ocular circulation induced by unilateral intravitreal injection of aflibercept in age-related maculopathy
Macular Diseases
RECOMMENDED
Related content
Macular Diseases
Effects of three intravitreal injections of aflibercept on the ocular circulation in eyes with age-related maculopathy
Br J Ophthalmol.
Mursch-Edlmayr AS, Luft N, Podkowinski D, Ring M, Schmetterer L, Bolz M
doi: 10.1136/bjophthalmol-
Macular Diseases
Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies
Adv Ther.
Carrasco J, Pietsch GA, Nicolas MP, Koerber C, Bennison C, Yoon J
doi: 10.1007/s12325-019-01147-6.
Macular Diseases
Short-time effect of intravitreal injections on retinal vascular oxygenation and vessel diameter in patients with diabetic macular oedema or neovascular age-related macular degeneration
Acta Ophthalmol.
Mitsch C, Pemp B, Pollreisz A, Gleiss A, Karst S, Scholda C, Sacu S, Schmidt-Erfurth U
doi: 10.1111/aos.14276.Visit the original publication at ncbi.nlm.nih.gov
Macular Diseases
Observation of curative effect of intravitreal injection of conbercept in wet age-related macular degeneration: Optical coherence tomography analysis after injection
Microsc Res Tech.
Yang W, Tan Y, Li C, Liu Y, Lu G
doi: 10.1002/jemt.22989.
Macular Diseases
AFLIBERCEPT AFTER RANIBIZUMAB INTRAVITREAL INJECTIONS IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: The ARI2 Study
Retina.
Blanco-Garavito R, Jung C, Uzzan J, Quaranta-ElMaftouhi M, Coscas F, Sahel J, Korobelnik JF, Béchet S, Querques G, Souied EH
doi: 10.1097/IAE.
Macular Diseases
One year effectiveness study of intravitreal aflibercept in neovascular age-related macular degeneration: a meta-analysis
Acta Ophthalmol.
Guo MY, Cheng J, Etminan M, Zafari Z, Maberley D
doi: 10.1111/aos.13825.
Glaucoma and Ocular PressureMacular DiseasesOcular Oncology
Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration
Invest Ophthalmol Vis Sci.
Wen JC, Reina-Torres E, Sherwood JM, Challa P, Liu KC, Li G, Chang JY, Cousins SW, Schuman SG, Mettu PS, Stamer WD, Overby DR, Allingham RR
doi: 10.1167/iovs.16-20786.
RECOMMENDED
Further Publications
Intravitreal Aflibercept Injection vs Sham as Prophylaxis Against Conversion to Exudative Age-Related Macular Degeneration in High-risk Eyes: A Randomized Clinical Trial
★ 3
Recommended by
Prof. Dr Ke Yao, Faculty Member
JAMA Ophthalmol
Heier JS, Brown DM, Shah SP, Saroj N, Dang S, Waheed NK, Wykoff CC, Prenner JL, Boyer DS
doi: 10.1001/jamaophthalmol.2021.0221
Macular DiseasesRetinal Diseases
One-year outcome of intravitreal ziv-aflibercept therapy for non-responsive neovascular age-related macular degeneration
Br J Ophthalmol.
Braimah IZ, Agarwal K, Mansour A, Chhablani J; Ziv-aflibercept Study Group
doi: 10.1136/bjophthalmol-